메뉴 건너뛰기




Volumn 46, Issue 8, 2008, Pages 1157-1164

Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; CLINDAMYCIN; COLISTIN; LINEZOLID; PIPERACILLIN PLUS TAZOBACTAM; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

EID: 42549119145     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/529439     Document Type: Article
Times cited : (142)

References (31)
  • 1
    • 3242775982 scopus 로고    scopus 로고
    • Surviving sepsis campaign guidelines for the management of severe sepsis and septic shock
    • Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for the management of severe sepsis and septic shock. Crit Care Med 2004; 32:858-73.
    • (2004) Crit Care Med , vol.32 , pp. 858-873
    • Dellinger, R.P.1    Carlet, J.M.2    Masur, H.3
  • 2
    • 0037090339 scopus 로고    scopus 로고
    • Clinical trials of immunomodulatory therapies in severe sepsis and septic shock
    • Vincent J-L, Sun Q, Dubois M-J. Clinical trials of immunomodulatory therapies in severe sepsis and septic shock. Clin Infect Dis 2002; 34:1084-93.
    • (2002) Clin Infect Dis , vol.34 , pp. 1084-1093
    • Vincent, J.-L.1    Sun, Q.2    Dubois, M.-J.3
  • 3
    • 3543117815 scopus 로고    scopus 로고
    • Macrolide activities beyond their antimicrobial effects: Macrolides in diffuse panbronchiolitis and cystic fibrosis
    • Schultz MJ. Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis. J Antimicrob Chemother 2004; 54:21-8.
    • (2004) J Antimicrob Chemother , vol.54 , pp. 21-28
    • Schultz, M.J.1
  • 4
    • 0036001168 scopus 로고    scopus 로고
    • Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-κB transcription factors
    • Kikuchi T, Hagiwara K, Honda Y, et al. Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-κB transcription factors. J Antimicrob Chemother 2002; 49:745-55.
    • (2002) J Antimicrob Chemother , vol.49 , pp. 745-755
    • Kikuchi, T.1    Hagiwara, K.2    Honda, Y.3
  • 5
    • 0347361713 scopus 로고    scopus 로고
    • Immunomodulatory clarithromycin treatment of experimental sepsis and acute pyelonephritis caused by multidrug-resistant Pseudomonas aeruginosa
    • Giamarellos-Bourboulis EJ, Adamis T, Laoutaris G, et al. Immunomodulatory clarithromycin treatment of experimental sepsis and acute pyelonephritis caused by multidrug-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 2004; 48:93-9.
    • (2004) Antimicrob Agents Chemother , vol.48 , pp. 93-99
    • Giamarellos-Bourboulis, E.J.1    Adamis, T.2    Laoutaris, G.3
  • 6
    • 12344261855 scopus 로고    scopus 로고
    • Clarithromycin co-administered with amikacin attenuates systemic inflammation in experimental sepsis by Escherichia coli
    • Giamarellos-Bourboulis EJ, Baziaka F, Antonopoulou A, et al. Clarithromycin co-administered with amikacin attenuates systemic inflammation in experimental sepsis by Escherichia coli. Int J Antimicrob Agents 2005; 25:168-72.
    • (2005) Int J Antimicrob Agents , vol.25 , pp. 168-172
    • Giamarellos-Bourboulis, E.J.1    Baziaka, F.2    Antonopoulou, A.3
  • 7
    • 13644266012 scopus 로고    scopus 로고
    • Clarithromycin: Immunomodulatory therapy of experimental sepsis and acute pyelonephritis by Escherichia coli
    • Giamarellos-Bourboulis EJ, Adamis T, Sabracos L, et al. Clarithromycin: immunomodulatory therapy of experimental sepsis and acute pyelonephritis by Escherichia coli. Scand J Infect Dis 2005; 37:48-54.
    • (2005) Scand J Infect Dis , vol.37 , pp. 48-54
    • Giamarellos-Bourboulis, E.J.1    Adamis, T.2    Sabracos, L.3
  • 8
    • 33644929201 scopus 로고    scopus 로고
    • Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistantPseudomonas aeruginosa
    • Giamarellos-Bourboulis EJ, Antonopoulou A, Raftogiannis M, et al. Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistantPseudomonas aeruginosa. BMC Infect Dis 2006; 6:31.
    • (2006) BMC Infect Dis , vol.6 , pp. 31
    • Giamarellos-Bourboulis, E.J.1    Antonopoulou, A.2    Raftogiannis, M.3
  • 9
    • 33645804394 scopus 로고    scopus 로고
    • Clarithromycin is an effective immunomodulator in experimental pyelonephritis caused by pan-resistant Klebsiella pneumoniae
    • Giamarellos-Bourboulis EJ, Tziortzioti V, Koutoukas P, et al. Clarithromycin is an effective immunomodulator in experimental pyelonephritis caused by pan-resistant Klebsiella pneumoniae. J Antimicrob Chemother 2006; 57:937-44.
    • (2006) J Antimicrob Chemother , vol.57 , pp. 937-944
    • Giamarellos-Bourboulis, E.J.1    Tziortzioti, V.2    Koutoukas, P.3
  • 10
    • 0034949783 scopus 로고    scopus 로고
    • Ventilator-associated pneumonia in a surgical intensive care unit: Epidemiology, etiology and comparison of three bronchoscopic methods for microbiological specimen sampling
    • Woske HJ, Röding T, Schulz I, Lode H. Ventilator-associated pneumonia in a surgical intensive care unit: epidemiology, etiology and comparison of three bronchoscopic methods for microbiological specimen sampling. Crit Care 2001; 5:167-73.
    • (2001) Crit Care , vol.5 , pp. 167-173
    • Woske, H.J.1    Röding, T.2    Schulz, I.3    Lode, H.4
  • 11
    • 13644257785 scopus 로고    scopus 로고
    • Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: A role for routine endotracheal aspirate cultures
    • Michel F, Franceschini B, Berger P, et al. Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures. Chest 2005; 127:589-97.
    • (2005) Chest , vol.127 , pp. 589-597
    • Michel, F.1    Franceschini, B.2    Berger, P.3
  • 13
    • 17944370018 scopus 로고    scopus 로고
    • Rello J, Paiva JA, Baraibar J, et al. International conference for the development of consensus on the diagnosis and treatment of ventilator-associated pneumonia. Chest 2001; 120:955-70.
    • Rello J, Paiva JA, Baraibar J, et al. International conference for the development of consensus on the diagnosis and treatment of ventilator-associated pneumonia. Chest 2001; 120:955-70.
  • 14
    • 0141785587 scopus 로고    scopus 로고
    • Diagnosis of ventilator-associated pneumonia
    • Baughman RP. Diagnosis of ventilator-associated pneumonia. Curr Opin Crit Care 2003; 9:397-402.
    • (2003) Curr Opin Crit Care , vol.9 , pp. 397-402
    • Baughman, R.P.1
  • 15
    • 3543151410 scopus 로고    scopus 로고
    • Ventilator-associated pneumonia
    • Vincent JL. Ventilator-associated pneumonia. J Hosp Infect 2004; 57:272-80.
    • (2004) J Hosp Infect , vol.57 , pp. 272-280
    • Vincent, J.L.1
  • 16
    • 0025809112 scopus 로고
    • Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid
    • Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991; 143:1121-9.
    • (1991) Am Rev Respir Dis , vol.143 , pp. 1121-1129
    • Pugin, J.1    Auckenthaler, R.2    Mili, N.3    Janssens, J.P.4    Lew, P.D.5    Suter, P.M.6
  • 18
    • 42549162568 scopus 로고    scopus 로고
    • Clarithromycin for intravenous injection: clinical expert report [data on file]. Abbott Park, IL: Abbott Laboratories, 1998.
    • Clarithromycin for intravenous injection: clinical expert report [data on file]. Abbott Park, IL: Abbott Laboratories, 1998.
  • 19
    • 19944429484 scopus 로고    scopus 로고
    • Ventilator associated pneumonia: Comparison between quantitative and qualitative cultures of tracheal aspirates
    • Camargo LFA, De Marco FV, Barbas CSV, et al. Ventilator associated pneumonia: comparison between quantitative and qualitative cultures of tracheal aspirates. Crit Care 2004; 8:R422-30.
    • (2004) Crit Care , vol.8
    • Camargo, L.F.A.1    De Marco, F.V.2    Barbas, C.S.V.3
  • 21
    • 33644909052 scopus 로고    scopus 로고
    • Evaluation of an intervention designed to decrease the role of nosocomial methicillin-resistant Staphylococcus aureus infection by encouraging decreased fluoroquinolone use
    • Madars-Kelly KJ, Remington RE, Lewis PG, Stevens DL. Evaluation of an intervention designed to decrease the role of nosocomial methicillin-resistant Staphylococcus aureus infection by encouraging decreased fluoroquinolone use. Infect Control Hosp Epidemiol 2006; 27:155-69.
    • (2006) Infect Control Hosp Epidemiol , vol.27 , pp. 155-169
    • Madars-Kelly, K.J.1    Remington, R.E.2    Lewis, P.G.3    Stevens, D.L.4
  • 22
    • 30344451643 scopus 로고    scopus 로고
    • Epidemiology and outcomes of health-care-associated pneumonia: Results froma large US database of culture-positive pneumonia
    • Kollef MH, Shorr A, Tabak YP, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results froma large US database of culture-positive pneumonia. Chest 2005; 128:3854-62.
    • (2005) Chest , vol.128 , pp. 3854-3862
    • Kollef, M.H.1    Shorr, A.2    Tabak, Y.P.3    Liu, L.Z.4    Johannes, R.S.5
  • 24
    • 27744470133 scopus 로고    scopus 로고
    • Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria
    • Giantsou E, Liratzopoulos N, Efraimidou E, et al. Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria. Intensive Care Med 2005; 31:1488-94.
    • (2005) Intensive Care Med , vol.31 , pp. 1488-1494
    • Giantsou, E.1    Liratzopoulos, N.2    Efraimidou, E.3
  • 25
    • 0346993417 scopus 로고    scopus 로고
    • Incidence, etiology, and outcome of nosocomial pneumonia in ICU patients requiring percutaneous tracheotomy for mechanical ventilation
    • Rello J, Lorente C, Diaz E, et al. Incidence, etiology, and outcome of nosocomial pneumonia in ICU patients requiring percutaneous tracheotomy for mechanical ventilation. Chest 2003; 124:2239-43.
    • (2003) Chest , vol.124 , pp. 2239-2243
    • Rello, J.1    Lorente, C.2    Diaz, E.3
  • 26
    • 13244291394 scopus 로고    scopus 로고
    • Anti-inflammatory effects of macrolides - an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    • Amsden GW. Anti-inflammatory effects of macrolides - an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother 2005; 55:10-21.
    • (2005) J Antimicrob Chemother , vol.55 , pp. 10-21
    • Amsden, G.W.1
  • 27
    • 0141816759 scopus 로고    scopus 로고
    • Azithromycin: In patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial
    • Saiman L, Marshall BC, Mayer-Hamblett, et al. Azithromycin: in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 2003; 290:1749-56.
    • (2003) JAMA , vol.290 , pp. 1749-1756
    • Saiman, L.1    Marshall, B.C.2    Hamblett, M.3
  • 28
    • 0037190575 scopus 로고    scopus 로고
    • Long term azithromycin in children with cystic fibrosis: A randomized, placebo-controlled crossover trial
    • Equi A, Balfour-Lynn IM, Bush A, Rosenthal M. Long term azithromycin in children with cystic fibrosis: a randomized, placebo-controlled crossover trial. Lancet 2002; 360:978-84.
    • (2002) Lancet , vol.360 , pp. 978-984
    • Equi, A.1    Balfour-Lynn, I.M.2    Bush, A.3    Rosenthal, M.4
  • 30
    • 4544277113 scopus 로고    scopus 로고
    • Regulatory effects of macrolides on bacterial virulence: Potential role as quorum sensing inhibitors
    • Takeda K, Standiford TJ, Pechère JC, Yamaguchi K. Regulatory effects of macrolides on bacterial virulence: potential role as quorum sensing inhibitors. Curr Pharm Des 2004; 10:3055-65.
    • (2004) Curr Pharm Des , vol.10 , pp. 3055-3065
    • Takeda, K.1    Standiford, T.J.2    Pechère, J.C.3    Yamaguchi, K.4
  • 31
    • 33846245519 scopus 로고    scopus 로고
    • Clarithromycin in the treatment of RSV bronchiolitis: A double-blind, randomised, placebo-controlled trial
    • Tahan F, Ozcan A, Koc N. Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial. Eur Respir J 2007; 29:91-7.
    • (2007) Eur Respir J , vol.29 , pp. 91-97
    • Tahan, F.1    Ozcan, A.2    Koc, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.